With opioid overdoses surging, harm-reduction groups are calling on the FDA to change naloxone’s prescription-only status. This would make it easier to get the lifesaving drug to people at risk. Read the Full Article.
Recent Posts
- Rutgers Scientists Develop Method to Detect Deadly Infectious Diseases.
- Rutgers Health Regional Biocontainment Lab Plans Renovation and Expansion.
- NJACTS Community Engagement Core Available Services
- Health clinic in Plainfield doubles its care for the uninsured.
- CDC panel approves revised COVID-19 vaccine.
Categories
- News (1,893)
- Publication (1)